Registration Is pleased to announce To register to attend, please go to: www.mskcc.org/cme Or contact: October 3, 2014 Office of Continuing Medical Education Memorial Sloan Kettering Cancer Center Dermatologic 633 Third Avenue, 12th Floor, New York, New York 10017 Care In Oncology (646) 227-2025 • [email protected] S y m p os i u m Co u r s e D i r e c t o r Mario E. Lacouture, MD Dermatologist Memorial Sloan Kettering MSK is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Commercial Support No commercial support has been provided for this activity. Memorial Sloan-Kettering Cancer Center does not accept commercial support for its CME activities. www.mskcc.org/cme Accreditation Statement For more information and to register go to: MSK designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. The AMA has determined that physicians not licensed in the United States but who participate in this CME activity are eligible for 4.5 AMA PRA Category 1 Credit(s)™. Care In Oncology S y m p os i u m AMA Credit Designation Statement Dermatologic This course is comprised of lectures and interactive audience participation encouraging the intellectual exchange of ideas between faculty and participants. It is the policy of MSK to make every effort to insure balance, independence, objectivity, and scientific rigor in all continuing medical education activities which it sponsors as an ACCME accredited provider. In accordance with ACCME guidelines and standards, all faculty participating in an activity sponsored by MSK are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services which are discussed by the faculty members in an educational presentation and/ or have provided support for this course. As required by the ACCME, when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, MSK requires the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational. , Course Design Faculty Disclosure October 3 2014 This course is directed towards Dermatologists, Oncologists, and Oncology Nurses. Office of Continuing Medical Education 633 Third Avenue, 12th floor, New York, New York 10017 Target Audience Conference Location Rockefeller Research Laboratories Building Ground Floor Conference Facility 430 East 67th Street (between First and York Avenues) www.mskcc.org/cme For more information and to register go to: scientific agenda COURSE OVERVIEW Chemotherapy, radiation, and therapeutic transplants Friday, October 3 have resulted in remarkable improvements in patient 8:00-9:00am Registration and Breakfast survival. Despite this remarkable success, the majority 9:00-9:10am Welcome and Background of treated patients will develop dermatologic adverse events, which lead to decreased quality of life and inconsistent antineoplastic regimens, both of which may affect clinical outcome. Therefore, attentive dermatologic Iris Amitay, MD 11:55am-12:15pm 12:15-1:00pm Skin Adverse Events Induced by Cyotoxic Chemotherapy (Alkylating, Antimetabolites, Topoisomerase inhibitors) 9:25-9:50am Milan Anadkat, MD Skin Adverse Events Induced by Cyotoxic Chemotherapy (Antimicrotubule, ATRA, arsenic trioxide, bleomycin, asparaginase) Christopher Barker, MD Rockefeller Research Laboratories Building Skin Adverse Events Induced by Chemotherapy (Proteasome Inhibitors, Immunotherapies (IFN, ipilimumab, thalidomide, lenalidomide) Jae Jung, MD Hair and Nail Toxicities 1:50-2:15pm 430 East 67th Street (between First and York Avenues) Beth McLellan, MD Rajesh Lalla, DMD Coffee Break 2:40-3:15pm Dermatologic Cancers and Procedures for the Non-Dermatologist 3:15-3:40pm Caroline Kim, MD Skin Adverse Events Induced by EGFR, mTOR, and RAF inhibitors Practical Skin Care Recommendations (Sunscreens, topical steroids, OTC products) 3:40-4:05pm Mario Lacouture, MD 11:10-11:30am Mucositis Incidence and Management 2:15-2:40pm Jennifer Choi, MD 10:45-11:10am Stem cell transplant Induced Adverse Events (i.e. GVHD) 1:25-1:50pm Nicole LeBoeuf, MD 10:20-10:45am Lunch Radiation Induced Adverse Events, Acute and Chronic 1:00-1:25pm Jae Jung, MD 9:50-10:15am Ground Floor Conference Facility QOL Measurement (ie Skindex, HFS14, FACT EGFRI 18) Mario Lacouture, MD care is critical for the optimization of anticancer therapies. Conference Location Skin Adverse Events Induced by Bcr-Abl, PDGFR, VEGFR Inhibitors Vincent Sibaud, MD Types of Dermatologic Reactions (EM, SJS/TEN, Rash Types), Grading (ie CTCAE, SCORTEN, 9s) 9:10-9:25am 11:30-12:00am Kathryn Ciccolini, RN Coffee Break 4:05-4:30pm Adjourn and Meet Faculty MSK Course Director M S K Co u r s e F a c u lt y G u e s t F a c u lt y G u e s t F a c u lt y G u e s t F a c u lt y Mario E. Lacouture, MD Christopher Barker, MD Milan Anadkat, MD Caroline Kim, MD Beth Israel Deaconess Medical Center Boston, MA Nicole Leboeuf Dana-Farber Cancer Institute Boston, MA Kathryn Ciccolini, RN Jennifer Choi, MD Iris Amitay Laish New York University New York, NY Jae Jung, MD, PhD Rajesh Lalla DDS, PhD Attending Dermatologist Memorial SloanKettering Cancer Center New York, NY Memorial Sloan-Kettering Cancer Center New York, NY Memorial Sloan-Kettering Cancer Center New York, NY Washington University School of Medicine St Louis, MO Yale Oncodermatology Clinic New Haven, CT City of Hope Cancer Center Duarte, CA Rabin Medical Center Petah Tikva, Israel University of Connecticut Health Center Farmington, CT Beth McLellan, MD Vincent Sibaud Cancer University Institute Toulouse, France
© Copyright 2024 ExpyDoc
